Page 217 - 《精细化工》2021年第7期
P. 217
第 7 期 王 帅，等: 公斤级阿维巴坦钠的合成工艺 ·1499·
廉，因此在工业生产中更具优势。 Ⅻ进行保护并合成ⅩⅢ，避免了使用价格昂贵的 9-
芴基甲氧基羰基，降低了生产成本，同时本步避免
使用光气试剂，更加有利于工业化生产。
（5）本工艺路线合成成本低，操作简便，反应
条件温和，产品质量良好，适合于工业化生产。
参考文献：
[1] WANG D Y, ABBOUD M I, MARKOULIDES M S, et al. The road
to avibactam: The first clinically useful non-β-lactam working
somewhat like a β-lactam[J]. Future Medicinal Chemistry, 2016,
8(10): 1063-1084.
[2] ZHAI T F (翟腾飞). Study on the synthetisis technology of
avibactam and tazobactam[D]. Beijing: Beijing University of
Chemical Technology (北京化工大学), 2016.
2.5 Ⅰ的合成条件优化和讨论 [3] CUI Z X ( 崔召 新 ). Synthesis and crystallization process of
avibactam key intermediates[D]. Jinan: University of Jinan (济南大
该步反应是氢化反应和磺化反应一锅法进行， 学), 2019.
工艺更简便。在后处理过程中，最初除去甲苯副产 [4] CASTANHEIRA M, SADER H S, FARRELL D J, et al. Activity of
ceftaroline-avibactam tested against Gram-negative organism
物时使用的是乙酸乙酯，但用 HPLC 检测发现乙酸 populations, including strains expressing one or more β-lactamases
乙酯会带走部分产物，用乙酸丁酯则基本不会带走 and methicillin-resistant Staphylococcus aureus carrying various
staphylococcal cassette chromosome mec types[J]. Antimicrobial
产物，季铵盐种类对Ⅰ收率的影响见表 2。如表 2 Agents and Chemotherapy, 2012, 56(9): 4779-4785.
[5] MEIR M, BIFANI P, BARKAN D. The addition of avibactam
所示，氢化反应和磺化反应结束后，需要利用季铵 renders piperacillin an effective treatment for Mycobacterium
盐和产物络合（如 XXIII）萃取得到有机相。本文 abscessus infection in an in vivo model[J]. Antimicrobial Resistance
and Infection Control, 2018, 151: 1-3.
对季铵盐进行了筛选，四正辛基溴化铵得到Ⅰ的收 [6] DUBREUIL L J, MAHIEUX S, NEUT C, et al. Anti-anaerobic
率最高，又考虑到四正辛基溴化铵较低的价格以及 activity of a new β-lactamase inhibitor NXL104 in combination with
β-lactams and metronidazole[J]. International Journal of
其固体形态，最终选取四正辛基溴化铵作为铵化试 Antimicrobial Agents, 2012, 39(6): 500-504.
剂进行反应。 [7] PAPP-WALLACE K M, NGUYEN N Q, JACOBS M R, et al.
Strategic approaches to overcome resistance against Gram-negative
pathogens using β-lactamase inhibitors and β-lactam enhancers:
表 2 季铵盐种类对Ⅰ收率的影响 Activity of three novel diazabicyclooctanes WCK 5153, zidebactam
Table 2 Effect of quaternary ammonium salt kinds on the (WCK 5107), and WCK 4234[J]. Journal of Medicinal Chemistry,
yield of Ⅰ 2018, 61(9): 4067-4086.
[8] YE H W (叶海伟), ZHOU L P (周丽萍), SHEN M J (沈敏杰), et al.
季铵盐 Ⅰ的收率/% Progresses in synthesis of avibactam[J]. Fine Chemical Intermediates
(精细化工中间体), 2017, 47(4): 9-14.
四正戊基溴化铵 49.5
[9] PEILLERON L, CARIOU K. Synthetic approaches towards
四正己基溴化铵 50.3 avibactam and other diazabicyclooctane β-lactamase inhibitors[J].
四正庚基溴化铵 55.7 Organic & Biomolecular Chemistry, 2020, 18(5): 830-844.
[10] ABE T, OKUE M, SAKAMAKI Y. Optically-active
三辛基甲基溴化铵 54.6 diazabicyclooctane derivative and method for manufacturing same:
四正辛基溴化铵 60.1 WO2012086241A1[P]. 2012-06-28.
[11] LEI S H (雷时海), WANG H Q (王洪强), XIAO J H (肖军海), et al.
Improved synthesis of avibactam[J]. Chinese Journal of Medicinal
Chemistry (中国药物化学杂志), 2016, 26(4): 297-302.
3 结论 [12] LAMPILAS M, ASZODI J, ROWLANDS D A, et al. New
azabicyclic compounds, useful as antibacterial agents for therapeutic
（1）设计了一条新的Ⅰ合成路线，并对其进行 use or as disinfectants, also new intermediate: CN1468242[P].
2001-07-24.
了实验条件优化，实现了公斤级规模的放大，Ⅰ的 [13] HIRAI Y, NISHIYAMA A. Method for producing optically active
总收率 19.7%，HPLC 纯度 99.81%。 bicyclic urea compound: WO2014069351A1[P]. 2014-05-08.
[14] MILLER S P, ZHONG Y L, LIU Z, et al. Practical and cost-effective
（2）选用 L-焦谷氨酸作为起始原料，利用其 2 manufacturing route for the synthesis of a β-lactamase inhibitor[J].
Organic Letters, 2014, 16(1): 174-177.
位手性中心，通过原位引入的方式直接构建Ⅰ的 2 [15] XIONG H, CHEN B, DURAND-REVILLE T F, et al.
位手性中心，采用氯化苄替代危险气体异丁烯便于 Enantioselective synthesis and profiling of two novel
diazabicyclooctanone β-lactamase inhibitors[J]. ACS Medicinal
HPLC 检测，并且其价格低廉利于工业化生产。 Chemistry Letters, 2014, 5(10): 1143-1147.
（3）利用硼氢化钠和丙酸制备的三丙酰氧基硼 [16] WANG T, DU L D, WAN D J, et al. Use of lipase catalytic resolution
in the preparation of ethyl (2S, 5R)-5-[(benzyloxy)amino] piperidine-
氢化钠作为还原试剂对肟进行还原，构建Ⅰ的 5 位 2-carboxylate, a key intermediate of the β-lactamase inhibitor
avibactam[J]. Organic Process Research & Development, 2018,
手性中心，主副异构体比例可达 4.38∶1，用二水草
22(12): 1738-1744.
酸拆分异构体，避免了柱色谱分离纯化的繁琐操作。 [17] BALL M, BOYD A, ENSOR G J, et al. Development of a
manufacturing route to avibactam, a β-lactamase inhibitor[J].
（4）首次利用价格低廉的二氯二甲基硅烷对Ⅹ Organic Process Research & Development, 2016, 20(10):1799-1805.
